5:30 PM
 | 
Feb 15, 2013
 |  BC Extra  |  Company News

FDA panel backs Guerbet imaging agent

FDA's Medical Imaging Drugs Advisory Committee unanimously recommended approval of Dotarem gadoterate meglumine from Guerbet S.A. (Euronext:GBT) to detect and visualize areas...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >